Effect of Early Treatment with Ivermectin among Patients with

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand - ScienceDirect

Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Marc Bailie on LinkedIn: Effect of Early Treatment with Ivermectin among Patients with Covid-19

Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients, Virology Journal

Ivermectin – time for action - Hospital Pharmacy EuropeHospital Pharmacy Europe

Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes - ScienceDirect

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients - ScienceDirect